ReviewFrontiers in cell and developmental biology2026
From cartilage degeneration to pain sensitization: a multi-tissue mitochondrial dysfunction network in osteoarthritis.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA) is one of the most common degenerative joint diseases, and its clinical burden arises not only from degenerative changes and synovial inflammation but is also closely associated with chronic pain, functional impairment, and reduced quality of life. In patients with OA, imaging-detected structural damage and pain severity are not always consistent, suggesting that symptom persistence may also be driven by mechanisms such as metabolic disturbance, inflammatory amplification, and neural sensitization. Existing evidence indicates that mitochondrial abnormalities can be observed in cartilage, synovium, subchondral bone, and sensory nerve-related compartments, but the strength of evidence and the causal hierarchy differ across compartments. In chondrocytes, disruption of mitochondrial homeostasis is often accompanied by imbalanced energy metabolism, oxidative stress, impaired quality control, and mtDNA damage, and is associated with cell aging, regulated cell death, and matrix degeneration. Mitochondrial stress in other joint and neural compartments may participate in local inflammation, abnormal bone remodeling, and peripheral and central pain sensitization. Mitochondria-derived DAMPs, and inflammatory mediators may mediate cross-compartment interactions, but current evidence is insufficient to establish a continuous causal chain from cartilage degeneration unidirectionally to pain sensitization. Therefore, mitochondria in OA are more appropriately regarded as a pathological network shared across multiple tissue compartments and potentially interacting with one another. Building on this perspective, this article takes pain sensitization as an important dimension for understanding structural damage and symptoms in OA, and uses the "metabolism-senescence-pain axis" as a hypothesis-generating framework to review the role of mitochondrial dysfunction in OA structural degeneration, cell aging, regulated cell death, and pain sensitization, with emphasis on distinguishing evidence across cartilage, synovium, subchondral bone, sensory neurons, and central nervous system-related compartments, and to discuss potential cross-compartment interactions mediated by DAMPs, and neuroimmune signaling. Furthermore, by integrating human, animal,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.